Surgery or active surveillance for pNETs < 2 cm: Preliminary results from a single center Brazilian cohort
- 11 June 2022
- journal article
- conference paper
- Published by Wiley in Journal of Surgical Oncology
- Vol. 126 (1) , 168-174
Abstract
Background and Objectives: Incidence of pancreatic neuroendocrine tumors (pNETS) seems to be rising over the years, with many cases incidentally diagnosed. Surgery and active surveillance are current treatment modalities for small pNETS. We review our institutional series and compare outcomes for small asymptomatic and nonfunctioning tumors.Methods: This retrospective cohort study included patients with 2 cm or less and well differentiated pNETS at a single Brazilian Cancer Center. From 2002 to 2020, patients received active surveillance or surgery as a treatment strategy. Short and long‐term results were compared.Results: Sixty‐four patients were included, 41 in surgical strategy and 23 in the active surveillance approach. Baseline group characteristics were comparable. More patients on active surveillance underwent abdominal magnetic resonance imaging (MRI) and had tumors located in the pancreatic head (41% vs. 17%, p = 0.038). Minimally invasive procedure was chosen in 80.1% of the surgical patients. No patient died after surgery. Median follow‐up period was 38.6 and 46.4 months for active surveillance and surgery cohorts, respectively. No difference in disease progression rate was observed.Conclusion: Both approaches seem to be safe for small pNETs. Long‐term outcome and quality of life should be considered when discussing such options with patients.Keywords
Funding Information
- Cancer Prevention and Research Institute of Texas
This publication has 17 references indexed in Scilit:
- Surveillance strategy for small asymptomatic non-functional pancreatic neuroendocrine tumors – a systematic review and meta-analysisHPB, 2017
- The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years AfterSurgery, 2017
- Is the 2-cm size cutoff relevant for small nonfunctioning pancreatic neuroendocrine tumors: A French multicenter studySurgery, 2016
- Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case–Control StudyAnnals of Surgical Oncology, 2015
- Surgical Resection Provides an Overall Survival Benefit for Patients with Small Pancreatic Neuroendocrine TumorsJournal of Gastrointestinal Surgery, 2015
- Impact of Extent of Surgery on Survival in Patients with Small Nonfunctional Pancreatic Neuroendocrine Tumors in the United StatesAnnals of Surgical Oncology, 2014
- Population-Level Analysis of Pancreatic Neuroendocrine Tumors 2 cm or Less in SizeAnnals of Surgical Oncology, 2013
- Implications of Incidentally Discovered, Nonfunctioning Pancreatic Endocrine TumorsArchives of Surgery, 2011
- The Clavien-Dindo Classification of Surgical ComplicationsAnnals of Surgery, 2009
- Evolving Patterns in the Detection and Outcomes of Pancreatic Neuroendocrine NeoplasmsArchives of Surgery, 2007